Jordan Johnson, Founding Partner at Bridge Oncology, Board Member at the National Association of Medication Access and Patient Advocacy (NAMAPA), Founder of The Healthcare Hub, shared a post on LinkedIn by Melissa Gowthrop, Radiation Oncology Coder/Auditor at Bridge Oncology, adding:
“This is exactly the conversation oncology leaders need to be having.
The biggest risks inside an oncology service line rarely announce themselves on a financial statement. They develop quietly – in fragmented workflows, misaligned incentives, reimbursement leakage, staffing inefficiencies, contracting gaps, underutilized assets, and decisions made without understanding how the entire service line fits together.
By the time those problems become visible at the enterprise level, the financial and operational damage is often already significant.
That is the gap Bridge Oncology was built to close.
Our work with oncology organizations increasingly spans the entire continuum – from strategy and clinical operations to revenue integrity, reimbursement, staffing, technology, contracting, compliance, and ultimately total cost of care.
The future of oncology will require more than optimizing individual departments or chasing reimbursement. It requires leaders who can see the entire oncology enterprise as one interconnected operating and economic model.
Great perspective here on where organizations are losing ground – and why closing the gap between strategy, operations, clinical care, and economics has become so important.”
Quoting Melissa Gowthrop’s post:
“Oncology service lines are losing ground in places leadership can’t see until it’s too late. Alongside Bridge Oncology leaders Jordan Johnson and Arpit Chhabra, I put together a few thoughts on where that gap actually lives, and where Bridge Oncology closes it.”
Other articles featuring Jordan Johnson on OncoDaily.